NYSE:MMM - 3M Stock Price, News, Headlines & Rumors

3M trades on the New York Stock Exchange (NYSE) under the ticker symbol "MMM."

3M declared a quarterly dividend on Tuesday, August 14th. Investors of record on Friday, August 24th will be given a dividend of $1.36 per share on Wednesday, September 12th. This represents a $5.44 annualized dividend and a yield of 2.70%. View 3M's Dividend History.

3M Co (NYSE:MMM) announced its earnings results on Tuesday, July, 24th. The conglomerate reported $2.59 earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of $2.58 by $0.01. The conglomerate had revenue of $8.39 billion for the quarter, compared to the consensus estimate of $8.36 billion. 3M had a return on equity of 51.31% and a net margin of 13.44%. 3M's quarterly revenue was up 7.4% on a year-over-year basis. During the same period last year, the firm posted $2.58 EPS. View 3M's Earnings History.

3M is scheduled to release their next quarterly earnings announcement on Tuesday, October, 23rd 2018. View Earnings Estimates for 3M.

3M issued an update on its FY18 earnings guidance on Tuesday, July, 24th. The company provided EPS guidance of $10.20-10.45 for the period, compared to the Thomson Reuters consensus EPS estimate of $10.33.

15 equities research analysts have issued 1 year price objectives for 3M's shares. Their forecasts range from $200.00 to $285.00. On average, they expect 3M's stock price to reach $228.80 in the next twelve months. This suggests a possible upside of 13.6% from the stock's current price. View Analyst Price Targets for 3M.

15 Wall Street analysts have issued "buy," "hold," and "sell" ratings for 3M in the last year. There are currently 4 sell ratings, 5 hold ratings and 6 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for 3M.

Some companies that are related to 3M include Becton Dickinson and (BDX), Stryker (SYK), Boston Scientific (BSX), FRESENIUS SE &/S (FSNUY), Baxter International (BAX), ABIOMED (ABMD), ResMed (RMD), DexCom (DXCM), Teleflex (TFX), Hill-Rom (HRC), ICU Medical (ICUI), Integra Lifesciences (IART), Haemonetics (HAE), Globus Medical (GMED) and Insulet (PODD).

Media coverage about MMM stock has trended somewhat positive recently, according to Accern Sentiment. The research firm identifies positive and negative press coverage by reviewing more than 20 million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. 3M earned a coverage optimism score of 0.11 on Accern's scale. They also assigned media stories about the conglomerate an impact score of 46.50 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company's share price in the next few days. View Recent Headlines for 3M.

3M's stock is owned by many different of retail and institutional investors. Top institutional shareholders include Massachusetts Financial Services Co. MA (1.94%), Bank of New York Mellon Corp (1.15%), FMR LLC (0.98%), US Bancorp DE (0.81%), Schwab Charles Investment Management Inc. (0.65%) and Morgan Stanley (0.62%). Company insiders that own 3M stock include Eric D Hammes, Frank R Jr Little, Hak Cheol Shin, Inge G Thulin, Ippocratis Vrohidis, Ivan K Fong, James L Bauman, Jon T Lindekugel, Julie L Bushman, Khandpur K Ashish, Kimberly F Price, Marlene Mary Mcgrath, Michael F Roman, Nicholas C Gangestad and Paul A Keel. View Institutional Ownership Trends for 3M.

MMM stock was sold by a variety of institutional investors in the last quarter, including FMR LLC, Robeco Institutional Asset Management B.V., Renaissance Technologies LLC, Russell Investments Group Ltd., Los Angeles Capital Management & Equity Research Inc., Canada Pension Plan Investment Board, Acadian Asset Management LLC and PNC Financial Services Group Inc.. Company insiders that have sold 3M company stock in the last year include Eric D Hammes, Frank R Jr Little, Hak Cheol Shin, Inge G Thulin, Ippocratis Vrohidis, Ivan K Fong, James L Bauman, Jon T Lindekugel, Khandpur K Ashish, Michael F Roman and Nicholas C Gangestad. View Insider Buying and Selling for 3M.

MMM stock was purchased by a variety of institutional investors in the last quarter, including Parnassus Investments CA, Charles Schwab Investment Advisory Inc., Cornerstone Wealth Management LLC, Bank of New York Mellon Corp, Morgan Stanley, Alecta Pensionsforsakring Omsesidigt, Banque Pictet & Cie SA and Massachusetts Financial Services Co. MA. View Insider Buying and Selling for 3M.

Shares of MMM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of MMM stock can currently be purchased for approximately $201.39.

3M has a market capitalization of $118.47 billion and generates $31.66 billion in revenue each year. The conglomerate earns $4.86 billion in net income (profit) each year or $9.17 on an earnings per share basis. 3M employs 91,536 workers across the globe.

3M's mailing address is 3M CENTER BLDG. 220-11W-02, ST PAUL MN, 55144. The conglomerate can be reached via phone at 651-733-1110.